Marketing-authorisation holder · United States
Grifols Biologicals LLC
30 medicines in 3 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
30 medicines in 3 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 30
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Albutein12.5ml/250ml · Injection | Albumin | United States | Marketed | 1978 |
| Albutein25g/500ml · Injection | Albumin | United States | Marketed | 1978 |
| Albutein25g/100ml · Injection | Albumin | United States | Marketed | 1978 |
| Albutein5g/100ml · Injection | Albumin | United States | Not marketed | 2022 |
| Albutein10g/50ml · Injection | Albumin | United States | Marketed | 1978 |
| Albutein20g/100ml · Injection | Albumin | United States | Marketed | 1978 |
| Albutein12.5g/50ml · Injection | Albumin | United States | Marketed | 1978 |
| Albutein5g/20ml · Injection | Albumin | United States | Marketed | 1978 |
| Albutein2.5g/50ml · Injection | Albumin | United States | Marketed | 1978 |
| ALBUTEIN 25% SOLN USP250 mg / ml · Solution | Albumin | Canada | Not marketed | 1989 |
| ALBUTEIN 5% SOLN USP50 mg / ml · Solution | Albumin | Canada | Not marketed | 1989 |
| ALPHANATE500 unit / vial + 600 unit / vial · Powder For Solution | Antihemophilic factor, Von willebrand factor | Canada | Authorised | |
| ALPHANATE1500 unit / vial + 1800 unit / vial · Powder For Solution | Antihemophilic factor, Von willebrand factor | Canada | Authorised | |
| ALPHANATE1000 unit / vial + 1200 unit / vial · Powder For Solution | Antihemophilic factor, Von willebrand factor | Canada | Authorised | |
| Alphanate250iu · For Injection | Antihemophilic factor/von willebrand factor complex | United States | Marketed | 1978 |
| ALPHANATE250 unit / vial + 300 unit / vial · Powder For Solution | Antihemophilic factor, Von willebrand factor | Canada | Authorised | |
| ALPHANATE2000 unit / vial + 2400 unit / vial · Powder For Solution | Antihemophilic factor, Von willebrand factor | Canada | Authorised | |
| Alphanate2000iu · For Injection | Antihemophilic factor/von willebrand factor complex | United States | Marketed | 2014 |
| Alphanate500iu · For Injection | Antihemophilic factor/von willebrand factor complex | United States | Marketed | 1978 |
| Alphanate1000iu · For Injection | Antihemophilic factor/von willebrand factor complex | United States | Marketed | 1978 |
| Alphanate1500iu · For Injection | Antihemophilic factor/von willebrand factor complex | United States | Marketed | 1978 |
| Alphanine, Alphanine Hp, Alphanine Sd1000iu · Injection | Coagulation factor ix | United States | Marketed | 1990 |
| Alphanine, Alphanine Hp, Alphanine Sd250iu · Injection | Coagulation factor ix | United States | Not marketed | 1990 |
| Alphanine, Alphanine Hp, Alphanine Sd500iu · Injection | Coagulation factor ix | United States | Marketed | 1990 |
| Alphanine, Alphanine Hp, Alphanine Sd1500iu · Injection | Coagulation factor ix | United States | Marketed | 1990 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 21 | 21 | 0 | CompaniesAll medicines |
| Canada | 7 | 7 | 0 | CompaniesAll medicines |
| Saudi Arabia | 2 | 2 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.